These findings are consistent with previous results in cross-sectional studies of pre-plaque TG mice that reported relatively rapid reversal of cognitive impairment by anti-Aß antibodies [50,51], BACE1 inhibitors [52] and γ-secretase inhibitors [53]. This evidence concerns the gene BACE1 and Cognitive impairment.